-48.0% below fair valueWould need to rise ~92.4% to reach fair value.
Scores are computed automatically from the real financial statements (Value from fair value; the rest from growth, profitability, balance sheet and dividends). A decision aid, not investment advice.
Revenue, net income and margin.
| Metric | FY'23 | FY'24 |
|---|---|---|
| Revenue | 61.36M | 36.71M |
| Net Income | 5.41M | -23.17M |
| Net Margin | 8.8% | -63.1% |
| Operating Cash Flow | -12.62M | 5.33M |
| OCF Margin | -20.6% | 14.5% |
| Capital Expenditure | -239.5K | -43.7K |
| Free Cash Flow | -12.86M | 5.28M |
| FCF Margin | -21.0% | 14.4% |
| FCF Conversion | -237.4% | 22.8% |
| EPS (Diluted) | 1.69/sh | -7.21/sh |
| Dividend / Share | 0.00/sh | 0.00/sh |
This company doesn’t currently pay a dividend, so there’s no income return to project. The fair-value gauge above covers the price side.
Dividend / share & historical yield (SAR).
No dividend history — this company doesn’t currently pay a dividend.
Fair value = median of the applicable methods (DCF).
Tune these per company in the Hajras Odoo backend; values recompute automatically.
What if you'd invested in Jana Medical Co. regularly?
No notes yet. Be the first to share a thesis.
AAOIFI-style financial screens on the latest annual figures.
Source: Maktab Al-Maqased (Sh. Al-Osaimi) — Annual Report FY2024
Measurable on 1 of 4 AAOIFI ratios; 3 not in this dataset.
Screening estimate, not a fatwa — we never pass a ratio without showing it. Verify with a qualified Shariah board.
Zakat due on a shareholding at today's price.
Long-term base uses cash & equivalents only (receivables and inventory are not in our data), so it understates zakat.
Zakat is due only after one full lunar year of ownership (hawl).
Estimate only, not a ZATCA filing — zakat on shares depends on intent (trading vs long-term). Consult a specialist.